Carazolol

A beta-adrenergic antagonist used in veterinary medicine

Carazolol
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Carazolol is a non-selective beta-adrenergic antagonist primarily used in veterinary medicine. It is known for its high affinity for beta-adrenergic receptors and is utilized in various animal species to manage stress and improve meat quality.

Pharmacology

Carazolol acts by blocking the action of catecholamines such as epinephrine and norepinephrine on beta-adrenergic receptors. This action results in decreased heart rate and reduced cardiac output, which can be beneficial in managing stress responses in animals.

Mechanism of Action

Carazolol binds to beta-adrenergic receptors, preventing the binding of endogenous catecholamines. This blockade leads to a decrease in the activation of adenylate cyclase, reducing the conversion of ATP to cAMP, and ultimately decreasing the physiological effects mediated by beta-adrenergic stimulation.

Uses in Veterinary Medicine

Carazolol is used in various animal species, including pigs, cattle, and poultry, to manage stress during transport and slaughter. It helps in reducing the incidence of stress-related conditions such as porcine stress syndrome and improves meat quality by minimizing glycogen depletion and lactic acid accumulation in muscles.

Side Effects

While carazolol is generally well-tolerated in animals, potential side effects include bradycardia, hypotension, and respiratory distress. Careful dosing and monitoring are essential to minimize adverse effects.

Regulatory Status

Carazolol is approved for use in veterinary medicine in several countries. However, its use is subject to strict regulations to ensure animal welfare and food safety.

Related pages

• Beta blocker
• Adrenergic receptor
• Veterinary medicine

• 

  Carazolol